Regulacje i polityka gospodarcza · 29/12/2022

National Cancer Institute to Grant Exclusive Patent License to Affini-T Therapeutics for Engineered Cell Therapies in Cancer Treatment

The National Cancer Institute, part of the National Institutes of Health, Department of Health and Human Services, is considering granting an exclusive patent license to Affini-T Therapeutics, Inc., a biotech company based in Watertown, MA, to develop and commercialize engineered cell therapies for cancer treatment.